Back to Search Start Over

CDK1-mediated BCL9 phosphorylation inhibits clathrin to promote mitotic Wnt signalling.

Authors :
Chen J
Rajasekaran M
Xia H
Kong SN
Deivasigamani A
Sekar K
Gao H
Swa HL
Gunaratne J
Ooi LL
Xie T
Hong W
Hui KM
Source :
The EMBO journal [EMBO J] 2018 Oct 15; Vol. 37 (20). Date of Electronic Publication: 2018 Sep 14.
Publication Year :
2018

Abstract

Uncontrolled cell division is a hallmark of cancer. Deregulation of Wnt components has been linked to aberrant cell division by multiple mechanisms, including Wnt-mediated stabilisation of proteins signalling, which was notably observed in mitosis. Analysis of Wnt components revealed an unexpected role of B-cell CLL/lymphoma 9 (BCL9) in maintaining mitotic Wnt signalling to promote precise cell division and growth of cancer cell. Mitotic interactome analysis revealed a mechanistic role of BCL9 in inhibiting clathrin-mediated degradation of LRP6 signalosome components by interacting with clathrin and the components in Wnt destruction complex; this function was further controlled by CDK1-driven phosphorylation of BCL9 N-terminal, especially T172. Interestingly, T172 phosphorylation was correlated with cancer patient prognosis and enriched in tumours. Thus, our results revealed a novel role of BCL9 in controlling mitotic Wnt signalling to promote cell division and growth.<br /> (© 2018 The Authors.)

Details

Language :
English
ISSN :
1460-2075
Volume :
37
Issue :
20
Database :
MEDLINE
Journal :
The EMBO journal
Publication Type :
Academic Journal
Accession number :
30217955
Full Text :
https://doi.org/10.15252/embj.201899395